Table 2: Bivariate analysis of patients without CT/RT and with CT/RT.

Variable

Without QT/RT (n =48)

With QT/RT (n=16)

Test

IC

Sex

Male

Female

 

 24 (50 %)

 24 (50 %)

 

8 (50 %)

8 (50 %)

 

X2

 

 

NO .754-1.327

SI .428-2.337

Age years

Median

Rank

 

65.5 (25-90)

 

69 (54-75)

p .000

t -31.5

 

-68.9 – (- 60.6)

Albumin gr/dl

 

Preoperative lymphocytes 1,000/mm3

3.56 (+ 0.51)

 

1.98 (+ 0.41)

3.43 (+ 0.44)

 

2.0 (+ 0.6)

p .000

t-36.6

p .000

t 7.8

1.3 – 1.7

 

1.0-1.8

CAE preoperative ng/L

5.7 UI/dl

(0.91-21.2)

5.4 UI/dl

(1.01-26.9)

 

 

Surgical Procedure

Lower anterior resection

Anterior resection

Posterior exenteration

Lower anterior resection with bowel resection

Lower anterior resection with partial cystectomy

Total pelvic exenteration

 

33 (68.7 %)

7 (14.5 %)

3 (6.2 %)

1 (2 %)

3 (6.2 %)

1 (2 %)

 

12 (75 %)

1 (6.2 %)

3 (18.7 %)

0

0

0

 

RR 6.2

p 0.49

 

Pathological clinical stage

complete

I

IIA

IIB

IIC

III

 

0

7 (14.5 %)

11 (22.9 %)

8 (16.6 %)

2 (4.1%)

20 (41.6 %)

 

1 (6.2 %)

0

3 (18.7 %)

2 (12.5 %)

1 (6.2 %)

9 (56.2 %)

 

RR 6.2

p 0.284

 

Complication

No

yes

 

31 (64.5 %)

17 (35.5 %)

 

14 (87.5 %)

2 (12.5 %)

 

X2 < 0.082

RR 3

 

.743-11.762

Postoperative complication

No

Dehicience of the anastomosis

Postoperative bleeding

Bowel lesion

ureteral lesion

Intrabdominal abscess

 

31 (64.5 %)

11 (22.9 %)

1 (2 %)

1 (2 %)

2 (4.1%)

2 (4.1 %)

 

12 (75 %)

2 (12.5 %)

0

1 (6.2 %)

0

1 (6.2 %)

 

RR 2.6

P 0.856

 

Recurrence

No

Local

Liver

Lung

Bone

Retroperitoneal and liver

Liver and lung

 

29 (60.4 %)

4 (8.3 %)

7 (14.5 %)

4 (6.25 %)

1 (1.56 %)

1 (1.56 %)

1 (1.56 %)

 

11 (68.7 %)

1 (6.2)

0

2 (12.5 %)

0

2 (12.5 %)

0

 

RR 6.1

P 0.409

 

Mortality

No

Yes

 

44 (91.6 %)

4 (8.4 %)

 

15 (93.7 %)

1 (6.3 %)

 

0.753

 

 

0.76-7.086